VIRIJEVIC, M.; KARAN-DJURASEVIC, T.; MARJANOVIC, I.; TOSIC, N.; MITROVIC, M.; DJUNIC, I.; COLOVIC, N.; VIDOVIC, A.; SUVAJDZIC-VUKOVIC, N.; TOMIN, D.; PAVLOVIC, S. Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukemia with normal karyotype. Radiology and Oncology, v. 50, n. 4, 21 Nov. 2016.